ELAN R&D to Revenue
Elanco Animal Health Incorporated Common Stock · R&D to Revenue
ELAN R&D to Revenue
Latest reported7.80%period ending
ELAN FY R&D/Revenue (10.00% → 7.80%)
Latest values, visible window
High-resolution chart · PNG
ELAN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 7.8049% | |
| 7.7495% | |
| 7.4032% | |
| 7.2773% | |
| 7.7456% | |
| 9.9899% | |
| 8.7952% | |
| 8.041% | |
| 8.7124% | |
| 9.123% | |
| 10.0031% |